Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Merck: Pharmakonzern verkauft US-Auftragsfertigung in die Schweiz

Der Darmstädter Dax-Konzern macht einen Deal im mittleren dreistelligen Millionenbereich mit dem Schweizer Unternehmen Lonza. Es geht um Standorte mit mehr als 1000 Jobs.

Original German Read in English

Merck: Pharmakonzern verkauft US-Auftragsfertigung in die Schweiz

We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at handelsblatt.com →

More in Health & Medicine

Teva and Samsung Bioepis Commercialize Two FDA-Approved Biosimilars in the U.S.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Samsung Bioepis Co., Ltd. today announced that they have entered into a license and commercialization agreement for two FDA-approved…

  • Teva and Samsung Bioepis license and commercialize two FDA-approved biosimilars in the U.S.
  • Infliximab-abda and ETICOVO are the biosimilars, targeting Remicade and Enbrel respectively.

More from Tuesday 3 November →